Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John G Cumming

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Drug Discovery Today|April 3, 2012
Better compounds faster: the development and exploitation of a desktop predictive chemistry toolkitJohn G Cumming, Jon Winter, Andrew Poirrette
Organic Letters|August 12, 2005
Stereocontrolled assembly of tetrasubstituted tetrahydrofurans: a concise synthesis of virgatusinTito Akindele, Stephen P Marsden, John G Cumming
Journal of Computer-Aided Molecular Design|July 25, 2024
From mundane to surprising nonadditivity: drivers and impact on ML modelsLaura Guasch, Niels Maeder, John G Cumming, et al.
Nature Reviews. Drug Discovery|November 30, 2013
Chemical predictive modelling to improve compound qualityJohn G Cumming, Andrew M Davis, Sorel Muresan, et al.
Journal of Chemical Information and Modeling|April 2, 2014
Beyond the scope of free-Wilson analysis. 2: Can distance encoded R-group fingerprints provide interpretable nonlinear models?Mats Eriksson, Hongming Chen, Lars Carlsson, et al.
Molecular Informatics|July 29, 2016
Automated QSAR with a Hierarchy of Global and Local ModelsDavid J Wood, David Buttar, John G Cumming, et al.
Future Medicinal Chemistry|March 22, 2014
Potential strategies for increasing drug-discovery productivityJohn G Cumming, M Raymond V Finlay, Fabrizio Giordanetto, et al.
ACS Medicinal Chemistry Letters|July 19, 2023
Discovery of a Series of Indane-Containing NBTIs with Activity against Multidrug-Resistant Gram-Negative PathogensJohn G Cumming, Lukas Kreis, Holger Kühne, et al.
Bioorganic & Medicinal Chemistry Letters|September 30, 2004
Novel, potent and selective anilinoquinazoline and anilinopyrimidine inhibitors of p38 MAP kinaseJohn G Cumming, Caroline L McKenzie, Stuart G Bowden, et al.
Bioorganic & Medicinal Chemistry Letters|January 24, 2012
Balancing hERG affinity and absorption in the discovery of AZD5672, an orally active CCR5 antagonist for the treatment of rheumatoid arthritisJohn G Cumming, Howard Tucker, John Oldfield, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Drug Discovery Today|April 3, 2012
Better compounds faster: the development and exploitation of a desktop predictive chemistry toolkitJohn G Cumming, Jon Winter, Andrew Poirrette
Organic Letters|August 12, 2005
Stereocontrolled assembly of tetrasubstituted tetrahydrofurans: a concise synthesis of virgatusinTito Akindele, Stephen P Marsden, John G Cumming
Journal of Computer-Aided Molecular Design|July 25, 2024
From mundane to surprising nonadditivity: drivers and impact on ML modelsLaura Guasch, Niels Maeder, John G Cumming, et al.
Nature Reviews. Drug Discovery|November 30, 2013
Chemical predictive modelling to improve compound qualityJohn G Cumming, Andrew M Davis, Sorel Muresan, et al.
Journal of Chemical Information and Modeling|April 2, 2014
Beyond the scope of free-Wilson analysis. 2: Can distance encoded R-group fingerprints provide interpretable nonlinear models?Mats Eriksson, Hongming Chen, Lars Carlsson, et al.
Molecular Informatics|July 29, 2016
Automated QSAR with a Hierarchy of Global and Local ModelsDavid J Wood, David Buttar, John G Cumming, et al.
Future Medicinal Chemistry|March 22, 2014
Potential strategies for increasing drug-discovery productivityJohn G Cumming, M Raymond V Finlay, Fabrizio Giordanetto, et al.
ACS Medicinal Chemistry Letters|July 19, 2023
Discovery of a Series of Indane-Containing NBTIs with Activity against Multidrug-Resistant Gram-Negative PathogensJohn G Cumming, Lukas Kreis, Holger Kühne, et al.
Bioorganic & Medicinal Chemistry Letters|September 30, 2004
Novel, potent and selective anilinoquinazoline and anilinopyrimidine inhibitors of p38 MAP kinaseJohn G Cumming, Caroline L McKenzie, Stuart G Bowden, et al.
Bioorganic & Medicinal Chemistry Letters|January 24, 2012
Balancing hERG affinity and absorption in the discovery of AZD5672, an orally active CCR5 antagonist for the treatment of rheumatoid arthritisJohn G Cumming, Howard Tucker, John Oldfield, et al.
Pageof 2